| Revenue growth | Consolidated Q2 +7.6%; H1 +9.3% |
|---|---|
| Margins | Standalone Q2 EBITDA 11.3% vs 13.1%; consolidated 9.6% vs 8.0% |
| Demand visibility | Pharma, research, academia demand; China Plus One tailwind cited |
Growth
Consolidated Q2 sales +7.6%, EBITDA +29.4%; H1 sales +9.3%. Standalone Q2 EBITDA down 9.7%.
Outlook
Glassware capacity ~15 to 108 lakh units (₹60 Cr, Mar 2027). Borosilicate tubing furnace (₹70 Cr, Mar 2028). Medium-term revenue CAGR 12-14%.
Risks
Middle East input-cost squeeze cut standalone EBITDA margin to 11.3% (13.1%). Consumer glassware sales -10.2%. Ind AS 115 hit consumables.
Investor Presentation filed with BSE, NSE: BOROSCI. Summary written with AI assistance from the document.
Borosil Scientific Ltd: key numbers
- Share price
- ₹101.73
- Market cap
- ₹904.9 Cr
- Revenue (annual)
- ₹467.3 Cr
- Net profit (annual)
- ₹34.61 Cr
- P/E (TTM)
- 19.9×Sector 45.0×
- Promoter holding
- 68.27%+0.00% QoQ
- FII holding
- 0.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Borosil Scientific Ltd
All →Borosil Scientific Capacity Expansion: ₹70 Cr Investment
Borosil Scientific approved a Rs.70 Crore, 20 MT per day glass tubing furnace. Commercial production is expected by March 2028.
- Value
- ₹70.00 Cr
- Execution
- Commercial production expected by March 31, 2028
- borosilicate glass tubing production capacity
- 20.0 MT per day
Borosil Scientific Q2 FY27 Results: Net Profit ₹5.3 Cr, Up 89.3% YoY
Borosil Scientific Ltd reported revenue from operations of ₹115 Cr (+7.6% YoY) and net profit of ₹5.3 Cr (+89.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.3 Cr · +89.3% YoY
Borosil Scientific Board Meeting Date
Borosil Scientific Limited will hold a board meeting on October 28, 2026, to consider and approve its unaudited financial results for the quarter ended September 30, 2026.
Borosil Scientific Other Announcement
Borosil Scientific Ltd submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026. This is a routine periodic regulatory disclosure.
Borosil Scientific Other Announcement
Borosil Scientific Limited filed the quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, as issued by its Registrar and Transfer Agent.
Borosil Scientific Annual General Meeting
Borosil Scientific Limited held its 35th Annual General Meeting on September 25, 2026, via video conferencing to transact business stated in the notice.